CLINICAL_TRIALS
research
· 2017-01-06
Clinical Trial Update: Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK
Summary
A clinical trial update evaluating whether anti-BK virus neutralizing antibodies can serve as a prognostic marker for the development of BK virus nephropathy in…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Strasbourg, France | Conditions: Graft Dysfunction | Status: UNKNOWN